Novartis Pharmaceuticals UK Limited provides a range of innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis in the UK is proud to be the largest initiator of clinical trials and offers a diversified portfolio to best meet the need of patients, from oncology to cardiology and respiratory. With its heritage firmly established with Novartis, severe asthma continues to be a key area of focus. For more information, please visit www.novartis.co.uk

RES18-E008 July 2018

Website: www.novartis.co.uk

Contact:

Sarah Pauling – Sarah.pauling@novartis.com